Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
IGC

IGC - India Globalization Capital Inc Stock Price, Fair Value and News

$0.280.00 (0.00%)
Market Closed

18/100

IGC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

18/100

IGC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

IGC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IGC Price Action

Last 7 days

-3.4%

Last 30 days

12%

Last 90 days

-20%

Trailing 12 Months

-15.1%

IGC RSI Chart

IGC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IGC Valuation

Market Cap

26.0M

Price/Earnings (Trailing)

-4.05

Price/Sales (Trailing)

23.51

EV/EBITDA

-4.26

Price/Free Cashflow

-4.62

IGC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

IGC Fundamentals

IGC Revenue

Revenue (TTM)

1.1M

Rev. Growth (Yr)

-53.64%

Rev. Growth (Qtr)

-41.77%

IGC Earnings

Earnings (TTM)

-6.4M

Earnings Growth (Yr)

-6.06%

Earnings Growth (Qtr)

-13.88%

IGC Profitability

Operating Margin

46.20%

EBT Margin

-582.82%

Return on Equity

-79.4%

Return on Assets

-65.94%

Free Cashflow Yield

-21.64%

IGC Investor Care

Shares Dilution (1Y)

19.91%

Diluted EPS (TTM)

-0.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.3M1.3M1.1M0
20241.3M1.1M1.2M1.2M
2023911.5K1.3M1.3M1.2M
2022397.0K532.0K678.0K868.0K
2021898.0K391.0K322.0K356.0K
20204.1M3.0M1.3M846.0K
20195.1M5.3M6.3M5.6M
20182.2M3.6M4.2M4.7M
2017793.5K557.9K630.7K1.1M
20166.4M4.8M2.9M2.1M
20157.7M8.8M8.7M7.3M
20142.3M3.6M5.0M6.3M
20138.0M7.9M7.7M3.8M
20124.2M4.4M4.8M7.8M
20114.1M4.0M3.2M3.7M
20100007.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About India Globalization Capital Inc

IGC
IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
 CEO
 WEBSITEhttps://igcpharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES61

India Globalization Capital Inc Frequently Asked Questions

IGC is the stock ticker symbol of India Globalization Capital Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of India Globalization Capital Inc is 26 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, IGC's PE ratio (Price to Earnings) is -4.05 and Price to Sales (PS) ratio is 23.51. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IGC PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, India Globalization Capital Inc has provided -0.067 (multiply by 100 for percentage) rate of return.